Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

1.

Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.

Bostom AG, Carpenter MA, Kusek JW, Hunsicker LG, Pfeffer MA, Levey AS, Jacques PF, McKenney J; FAVORIT Investigators.

Am Heart J. 2006 Sep;152(3):448.e1-7.

PMID:
16923411
[PubMed - indexed for MEDLINE]
2.

Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.

Sunder-Plassmann G, Winkelmayer WC, Födinger M.

Expert Opin Investig Drugs. 2000 Nov;9(11):2637-51. Review.

PMID:
11060826
[PubMed - indexed for MEDLINE]
3.

Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.

Suliman ME, Lindholm B, Bárány P, Qureshi AR, Stenvinkel P.

Semin Dial. 2007 Nov-Dec;20(6):523-9. Review.

PMID:
17991198
[PubMed - indexed for MEDLINE]
4.

Homocysteine, B-vitamins and CVD.

McNulty H, Pentieva K, Hoey L, Ward M.

Proc Nutr Soc. 2008 May;67(2):232-7. doi: 10.1017/S0029665108007076. Review.

PMID:
18412997
[PubMed - indexed for MEDLINE]
5.

The controversy over homocysteine and cardiovascular risk.

Ueland PM, Refsum H, Beresford SA, Vollset SE.

Am J Clin Nutr. 2000 Aug;72(2):324-32. Review.

PMID:
10919921
[PubMed - indexed for MEDLINE]
Free Article
6.

Treatment of hyperhomocysteinemia in end-stage renal disease.

Shemin D, Bostom AG, Selhub J.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S91-4. Review.

PMID:
11576930
[PubMed - indexed for MEDLINE]
8.

Homocysteine lowering and cardiovascular disease risk: lost in translation.

Marcus J, Sarnak MJ, Menon V.

Can J Cardiol. 2007 Jul;23(9):707-10. Review.

PMID:
17622392
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?

De Vriese AS, Verbeke F, Schrijvers BF, Lameire NH.

Kidney Int. 2002 Apr;61(4):1199-209. Review.

PMID:
11918726
[PubMed - indexed for MEDLINE]
Free Article
10.

Homocysteine-lowering therapy in renal disease.

Austen SK, Coombes JS, Fassett RG.

Clin Nephrol. 2003 Dec;60(6):375-85. Review.

PMID:
14690253
[PubMed - indexed for MEDLINE]
11.

Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.

Taylor BV, Oudit GY, Evans M.

Can Fam Physician. 2000 Nov;46:2236-45. Review.

PMID:
11143583
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.

Suliman ME, Lindholm B, Bárány P, Bergström J.

Clin Chem Lab Med. 2001 Aug;39(8):734-8. Review.

PMID:
11592443
[PubMed - indexed for MEDLINE]
13.

[Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].

Birn H.

Ugeskr Laeger. 2008 Mar 10;170(11):933-7. Review. Danish.

PMID:
18397619
[PubMed - indexed for MEDLINE]
14.

Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.

Suliman ME, Stenvinkel P, Bárány P, Heimbürger O, Anderstam B, Lindholm B.

Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S89-95. Review.

PMID:
12612961
[PubMed - indexed for MEDLINE]
15.

Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.

Carlsson CM.

Drugs Aging. 2006;23(6):491-502. Review.

PMID:
16872232
[PubMed - indexed for MEDLINE]
16.

Homocysteine and cardiovascular disease: a review of the evidence.

Wierzbicki AS.

Diab Vasc Dis Res. 2007 Jun;4(2):143-50. Review.

PMID:
17654449
[PubMed - indexed for MEDLINE]
Free Article
17.

Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications.

Perna AF, Ingrosso D, Castaldo P, De Santo NG, Galletti P, Zappia V.

Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):95-9. Review.

PMID:
10207268
[PubMed - indexed for MEDLINE]
18.

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

B-Vitamin Treatment Trialists' Collaboration.

Am Heart J. 2006 Feb;151(2):282-7. Review.

PMID:
16442889
[PubMed - indexed for MEDLINE]
19.

Homocysteine and cardiovascular disease in diabetes mellitus.

Audelin MC, Genest J Jr.

Atherosclerosis. 2001 Dec;159(2):497-511. Review.

PMID:
11730832
[PubMed - indexed for MEDLINE]
20.

Assessing plasma total homocysteine in patients with end-stage renal disease.

Urquhart BL, House AA.

Perit Dial Int. 2007 Sep-Oct;27(5):476-88. Review.

PMID:
17704433
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk